Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From DePuy Synthes
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
Despite COVID-19, the market for extremity replacement implants looks healthy in the medium-term, with strong growth predicted as elective surgeries return.
J&J expects its medical device sales to begin growing rapidly by the middle of 2021 as the pandemic subsides.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive